Product Information
BUDESONIDE ER 9 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $16.5829 per EA under NDC 00591251030. Its NADAC has been published 410 times since Oct 17, 2018.
FDA first approved this application on Jul 3, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
9 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591251030
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205457FDA Approved
7/3/2018
TE Code
AB
On Market Since
7/5/2018
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE ER 9 MG TABLET has been published 410 times since Oct 17, 2018, and over the history we have for it it has declined 60.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.5829 per EA |
|---|---|
| All-time high | $44.5486 (Dec 12, 2018) |
| All-time low | $11.9909 (May 20, 2026) |
| 52-week high | $18.6414 |
| 52-week low | $11.9909 |
| Median price | $31.2734 |
| Average price | $28.5457 |
| Largest weekly change | -35.3% (Apr 17, 2024) |
| Weeks tracked | 410 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUDESONIDE ER 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE ER 9 MG TABLET, manufactured by Actavis Pharma, Inc., is $16.5829 per EA (NDC 00591251030), effective Aug 19, 2026.
How has the price of BUDESONIDE ER 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUDESONIDE ER 9 MG TABLET has declined 60.7%. It has been tracked across 410 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for BUDESONIDE ER 9 MG TABLET?
Since Oct 17, 2018, the NADAC for BUDESONIDE ER 9 MG TABLET has ranged from a low of $11.9909 (May 20, 2026) to a high of $44.5486 (Dec 12, 2018), with a median of $31.2734 per EA.
Are there cheaper alternatives to BUDESONIDE ER 9 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BUDESONIDE ER 9 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE ER 9 MG TABLET?
BUDESONIDE ER 9 MG TABLET (NDC 00591251030) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.